伊玛提克斯 IMTX
$6.36 +$0.18 (+2.91%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $6.36 0.00%
开盘$6.18
昨收$6.18
当日区间$6.09 – $6.42
成交量1.06M
市值$951.68M
市盈率（TTM）–
股息率–
IMTX 相关新闻
匹配 Immatics 或代码 IMTX 的头条新闻，按最新排序。
- Jefferies Maintains Immatics(IMTX.US) With Buy Rating, Cuts Target Price to $17 负面
- Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $25
- TD Cowen Maintains Immatics(IMTX.US) With Buy Rating
- Goldman Sachs Maintains Immatics(IMTX.US) With Buy Rating, Cuts Target Price to $11.8 负面
- BofA Securities Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $17
- Earnings Flash (IMTX) Immatics Posts Q2 Revenue 9.1M Euros, Vs. FactSet Est of 10.4M Euros
- Chardan Capital Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $25
- Goldman Sachs Maintains Immatics(IMTX.US) With Buy Rating, Raises Target Price to $12.2 正面
- Guggenheim Maintains Immatics(IMTX.US) With Buy Rating, Maintains Target Price $19
- TD Cowen Initiates Immatics(IMTX.US) With Buy Rating
- Leerink Partners Maintains Immatics(IMTX.US) With Buy Rating, Announces Target Price $17
- Analysts Conflicted on These Healthcare Names: Siemens Healthineers AG (OtherSEMHF), Immatics (IMTX) and Aardvark Therapeutics, Inc. (AARD)
- Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG)
- Jefferies Initiates Immatics(IMTX.US) With Buy Rating, Announces Target Price $18
- Mizuho Securities Maintains Immatics(IMTX.US) With Buy Rating, Announces Target Price $25
暂无评论——快来第一个聊聊 IMTX。
登录后参与讨论。